As part of their Fourth Quarter and Full Year 2025 Financial Results release, Shoulder Innovations (NYSE: SI) publicly highlighted their strategic partnership with Interventional Systems (INS) to develop a shoulder-specific micro-robotic solution for total and reverse shoulder arthroplasty. The spotlight placed on this initiative reflects the confidence SI’s leadership has in the direction the two companies are building toward together.
Shoulder Innovations on the partnership
The robotic solution in development is designed to integrate directly with SI’s ProVoyance platform, already used in virtually all of their implant procedures, creating a connected workflow from preoperative planning through intraoperative execution. SI’s leadership described the partnership as a key pillar of their enabling technology strategy going into 2026 and confirmed that early cadaveric sessions have validated the technology clinically, with strong feedback from surgeon partners.
What sets the robotic platform apart
SI’s leadership pointed to two aspects of the solution as key differentiators in the shoulder arthroplasty market.
The first is the economic model. The robot functions as a portable unit on a case-by-case basis, eliminating the capital burden associated with traditional surgical robotic systems. This robotics-as-a-service approach is especially relevant as shoulder procedures continue shifting toward ambulatory surgery centers, where cost efficiency and ease of implementation are critical.
The second is workflow compatibility. Unlike systems that require fundamental changes to bone preparation or surgical technique, this solution requires minimal adjustment from surgeons. As SI described it, a procedure planned with the robot looks essentially identical to one planned without it, but with greater speed and accuracy in execution.
A longer-term vision
Beyond near-term efficiency gains, SI’s leadership spoke to a longer-term innovation cycle that robotic-enabled surgery can unlock — including new surgical approaches and implant technologies that could meaningfully reshape shoulder arthroplasty. We share that vision and see this partnership as a foundation for continued development.
For the full earnings release and conference call details, visit Shoulder Innovations’ Investor Relations page.
